Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
THB335 Phase 1 SAD/MAD clinical trial progressing; study now on track to report clinical results in 1Q’25 Strong financial position...
News
Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Over 122,000 prescriptions for VOQUEZNA® products written by healthcare providers, launch to date, a 184% increase since last quarterly reportNet...
Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September
COPENHAGEN, Denmark, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in...
Ocuphire Pharma to Present at Two Investor Conferences in August
FARMINGTON HILLS, Mich., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused...
Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused...
Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
Received FDA Breakthrough Therapy Designation for atacicept in IgA Nephropathy (IgAN)Presented data from Phase 2b ORIGIN study at ERA24 Congress...
Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis
– Phase 1 human clinical study of PALI-2108 for the treatment of Ulcerative Colitis (UC) on track to commence before...
GN further extends the ReSound Nexia family and releases updated fitting software designed for enhanced efficiency and usability
Building on the existing ReSound Nexia™ platform, the GN Group is launching its smallest wireless In-the-Canal (ITC) hearing aid in a...
SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers
SphingoTec GmbH has successfully secured funding to drive its global expansion, including the US market, through strategic collaborations.The investment round...
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
Key scientific achievement advances the joint neuroscience pipeline and earns a payment of US$ 25 m to Evotec to progress...
Kuros Biosciences Reports First Half of 2024 Results
Financial HighlightsDirect MagnetOs™ sales increased by 159% to CHF 31.6 million from CHF 12.2 million in H1 2023; this corresponds...
Healthcare Revenue Cycle Management (RCM) Software Market size is set to grow by USD 34.8 billion from 2024-2028, Growing need for reducing revenue leakage in healthcare system boost the market, Technavio
NEW YORK, Aug. 7, 2024 /PRNewswire/ -- The global healthcare revenue cycle management (RCM) software market size is estimated to grow...
MyndTec Inc. Announces the MyndMove System’s Showcase at the Dearborn 2024 Para Dance Sport International Competition & USA Open and Celebrates the Updated Health Canada License for the MyndMove System to Treat Lower Limb
Mississauga, Ontario--(Newsfile Corp. - August 7, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in...
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on...
Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo” or the “Company”) (OTCQX: SONX), a leading dental technology company and developer of the...
Outset Medical Reports Second Quarter 2024 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology...
Medexus Announces Strong Fiscal Q1 2025 Results
Fiscal Q1 2025 revenue of $27.3 million, net income of $2.0 million, operating income of $4.0 million, and Adjusted EBITDA*...
MARPAI REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
Company continues to drive towards profitability TAMPA, Fla., Aug. 7, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology...
Waystar Reports Second Quarter 2024 Results
Revenue growth of 20% year-over-year Net loss of $27.7 million and non-GAAP net income of $5.0 million Net loss margin...